Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,774
datasets available to search
ShareScore release 0.9.0
Dataset results
2,774 results for “Agent”
AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL
ClinicalTrials.gov study NCT05140382. IPD Sharing: YES. Countries: 8. Publications: 0.
A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00992186. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01893372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Positron Emission Tomography (PET) Contrast Agent Kinetics and Safety: [18F]-Fluoromannitol
ClinicalTrials.gov study NCT07110519. IPD Sharing: YES. Countries: 1. Publications: 0.
Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
ClinicalTrials.gov study NCT00629083. IPD Sharing: Not stated. Countries: 3. Publications: 0.
MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
ClinicalTrials.gov study NCT02551055. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01717482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
ClinicalTrials.gov study NCT01017796. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway
ClinicalTrials.gov study NCT01868022. IPD Sharing: YES. Countries: 7. Publications: 0.
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
ClinicalTrials.gov study NCT00378482. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
ClinicalTrials.gov study NCT05596422. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT02591095. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents
ClinicalTrials.gov study NCT03242915. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty
ClinicalTrials.gov study NCT01285024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
ClinicalTrials.gov study NCT02068846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent
ClinicalTrials.gov study NCT02084628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
ClinicalTrials.gov study NCT01820364. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents
ClinicalTrials.gov study NCT03285594. IPD Sharing: NO. Countries: 8. Publications: 0.
A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors
ClinicalTrials.gov study NCT03497429. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05362942. IPD Sharing: NO. Countries: 0. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.